Close Menu

NEW YORK (GenomeWeb) – Geneseq Biosciences and Australian Clinical Labs today announced a partnership to commercialize a noninvasive melanoma test.

The partners will offer the blood-based test, called Melaseq, which was developed by Geneseq for detecting melanoma signatures. Tissue samples can also be used for Melaseq, they said.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Jul
31
Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.